Cargando…

The role of N-Myc gene amplification in neuroblastoma childhood tumour – single-centre experience

AIM OF THE STUDY: Neuroblastoma (NBL) is one of the most common extracranial tumours occurring in children with N-Myc gene amplification, acknowledged as a marker of poor prognosis. We assessed the frequency of N-Myc amplification and its impact on NBL markers and on the treatment outcome. MATERIAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaczówka, Przemysław, Wieczorek, Aleksandra, Czogała, Małgorzata, Książek, Teofila, Szewczyk, Katarzyna, Balwierz, Walentyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377415/ https://www.ncbi.nlm.nih.gov/pubmed/30783385 http://dx.doi.org/10.5114/wo.2018.81402

Ejemplares similares

Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
por: Szewczyk, Katarzyna, et al.
Publicado: (2019)

Go with the Flow—Early Assessment of Measurable Residual Disease in Children with Acute Lymphoblastic Leukemia Treated According to ALL IC-BFM2009
por: Pawinska-Wasikowska, Katarzyna, et al.
Publicado: (2022)

Clinical Utility of Ammonia Concentration as a Diagnostic Test in Monitoring of the Treatment with L-Asparaginase in Children with Acute Lymphoblastic Leukemia
por: Czogała, Małgorzata, et al.
Publicado: (2014)

The Role of Id2 Protein in Neuroblatoma in Children
por: Wieczorek, Aleksandra, et al.
Publicado: (2015)

Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings—Real-World Data
por: Wieczorek, Aleksandra, et al.
Publicado: (2023)

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study
por: Ussowicz, Marek, et al.
Publicado: (2021)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
por: Cwiklinska, Magdalena, et al.
Publicado: (2020)

Monitoring of treatment with L-asparaginase in children with acute lymphoblastic leukaemia, with a focus on silent inactivation and its influence on the treatment outcome
por: Czogala, Malgorzata, et al.
Publicado: (2022)

Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group
por: Wieczorek, Aleksandra, et al.
Publicado: (2022)

The Malposition of Central Venous Catheters in Children
por: Dzierzega, Maria, et al.
Publicado: (2014)

Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia
por: Pawinska-Wasikowska, Katarzyna, et al.
Publicado: (2022)

Genetic Profile and Clinical Implications of Hepatoblastoma and Neuroblastoma Coexistence in a Child
por: Skoczen, Szymon, et al.
Publicado: (2019)

High Frequency of Fusion Gene Transcript Resulting From t(10;11)(p12;q23) Translocation in Pediatric Acute Myeloid Leukemia in Poland
por: Ksiazek, Teofila, et al.
Publicado: (2020)

MYC amplifications are common events in childhood osteosarcoma
por: De Noon, Solange, et al.
Publicado: (2021)

Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
por: Combaret, V., et al.
Publicado: (1997)

Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy
por: Lode, Holger N., et al.
Publicado: (2023)

Cytostatic and cytotoxic effects of tyrphostin AG1296 on RMS cells
por: Lasota, Małgorzata, et al.
Publicado: (2012)

Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy—Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022
por: Czogała, Małgorzata, et al.
Publicado: (2023)

Treatment Outcome and the Genetic Characteristics of Acute Promyelocytic Leukemia in Children in Poland From 2005 to 2018
por: Czogała, Małgorzata, et al.
Publicado: (2020)

HAUSP deubiquitinated and stabilizes N-Myc in neuroblastoma
por: Tavana, Omid, et al.
Publicado: (2016)

Characteristics and Outcome of FLT3-ITD-Positive Pediatric Acute Myeloid Leukemia—Experience of Polish Pediatric Leukemia and Lymphoma Study Group from 2005 to 2022
por: Czogała, Małgorzata, et al.
Publicado: (2023)

Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019
por: Czogała, Małgorzata, et al.
Publicado: (2021)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours
por: Lillington, D M, et al.
Publicado: (2002)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity
por: Fonseka, Pamali, et al.
Publicado: (2019)

Methylation and Expression of FTO and PLAG1 Genes in Childhood Obesity: Insight into Anthropometric Parameters and Glucose–Lipid Metabolism
por: Czogała, Wojciech, et al.
Publicado: (2021)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

Development of treatment and clinical results in childhood acute myeloid leukemia in Poland
por: Balwierz, Walentyna, et al.
Publicado: (2012)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
por: Kwiecinska, Kinga, et al.
Publicado: (2018)

Dissecting transcriptional amplification by MYC
por: Nie, Zuqin, et al.
Publicado: (2020)

Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
por: Bellini, Angela, et al.
Publicado: (2021)

One-step reverse transcription loop-mediated isothermal amplification (RT-LAMP) for detection of tomato torrado virus
por: Budziszewska, Marta, et al.
Publicado: (2016)

Venetoclax Use in Paediatric Haemato-Oncology Centres in Poland: A 2022 Survey
por: Bobeff, Katarzyna, et al.
Publicado: (2023)

Retrospective Analysis of the Treatment Outcome in Myeloid Leukemia of Down Syndrome in Polish Pediatric Leukemia and Lymphoma Study Group From 2005 to 2019
por: Czogala, Malgorzata, et al.
Publicado: (2020)

Elevated Asymmetric Dimethylarginine in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Preliminary Report
por: Sulicka, Joanna, et al.
Publicado: (2012)

MYC amplification in leukemia detected by cytogenetics
por: Safranauskas, Roberta Maria da Silva Oliveira, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3623v118p5plrnebr3qmeu0phv